borderline significantp = 0.064
Male patients were more prevalent in the CS group ( n = 20), compared to AHF ( n = 11) and controls ( n = 13), with this difference among groups being borderline significant ( p = 0.064).
Male patients were more prevalent in the CS group ( n = 20), compared to AHF ( n = 11) and controls ( n = 13), with this difference among groups being borderline significant ( p = 0.064).
Survivors: 6.2 (2.4; 9.8) ng/ml), these differences did not reach statistical significance ( p = 0.158).